Comparative Study of Nalbuphine and Midazolam Effects on Hemodynamic Responses During Orthopedic Surgeries

Background: Hemodynamic instability during orthopedic surgery is a major contributor to perioperative morbidity, yet the comparative effects of commonly used anesthetic agents such as nalbuphine and midazolam on cardiovascular parameters remain underexplored. Objective: This study aimed to compare the perioperative effects of nalbuphine and midazolam on hemodynamic stability—including mean arterial pressure, heart rate, and blood pressure—in adult patients undergoing elective orthopedic surgery. Methods: In this prospective comparative study, 60 adult patients (n = 30 per group) scheduled for elective orthopedic procedures were randomized to receive either intravenous nalbuphine or midazolam. Inclusion criteria encompassed ASA physical status I–II adults aged 18–65 years; patients with cardiovascular or respiratory disease, hypersensitivity to study drugs, or chronic opioid/sedative use were excluded. Hemodynamic parameters were monitored preoperatively, intraoperatively, and postoperatively using calibrated multiparametric monitors. The primary outcome was perioperative mean arterial pressure, with secondary outcomes including incidence of tachycardia and hypotension. Data were analyzed using SPSS version 27 with t-tests, chi-square, and repeated measures ANOVA. The study protocol was approved by the institutional ethics board and complied with the Declaration of Helsinki. Results: The nalbuphine group demonstrated significantly higher intraoperative mean arterial pressure (92 ± 6 mmHg vs. 85 ± 8 mmHg, p = 0.02) and reduced incidence of tachycardia (15% vs. 35%, p = 0.04) and hypotension (10% vs. 30%, p = 0.04) compared to the midazolam group, reflecting improved hemodynamic stability. Conclusion: Nalbuphine offers superior perioperative hemodynamic stability compared to midazolam, suggesting its preferential use in orthopedic patients at risk for cardiovascular fluctuations and highlighting its value in optimizing surgical safety and recovery

Authors

Institutions

Publication Details

Journal
Journal of Health Wellness and Community Research
Published
2025-05-24
DOI
https://doi.org/10.61919/axnba550
Primary Topic
Cardiac, Anesthesia and Surgical Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Study of Nalbuphine and Midazolam Effects on Hemodynamic Responses During Orthopedic Surgeries

Aamira Tariq, Rabia Javaid, Muhammad Usman Tariq, Shakir Hussain et al.
Journal of Health Wellness and Community Research
Cardiac, Anesthesia and Surgical Outcomes
article

Comparative Study of Nalbuphine and Midazolam Effects on Hemodynamic Responses During Orthopedic Surgeries

Aamira Tariq, Rabia Javaid, Muhammad Usman Tariq, Shakir Hussain, Mohsin Raza, Zoya Nadeem
article en

Abstract

Background: Hemodynamic instability during orthopedic surgery is a major contributor to perioperative morbidity, yet the comparative effects of commonly used anesthetic agents such as nalbuphine and midazolam on cardiovascular parameters remain underexplored. Objective: This study aimed to compare the perioperative effects of nalbuphine and midazolam on hemodynamic stability—including mean arterial pressure, heart rate, and blood pressure—in adult patients undergoing elective orthopedic surgery. Methods: In this prospective comparative study, 60 adult patients (n = 30 per group) scheduled for elective orthopedic procedures were randomized to receive either intravenous nalbuphine or midazolam. Inclusion criteria encompassed ASA physical status I–II adults aged 18–65 years; patients with cardiovascular or respiratory disease, hypersensitivity to study drugs, or chronic opioid/sedative use were excluded. Hemodynamic parameters were monitored preoperatively, intraoperatively, and postoperatively using calibrated multiparametric monitors. The primary outcome was perioperative mean arterial pressure, with secondary outcomes including incidence of tachycardia and hypotension. Data were analyzed using SPSS version 27 with t-tests, chi-square, and repeated measures ANOVA. The study protocol was approved by the institutional ethics board and complied with the Declaration of Helsinki. Results: The nalbuphine group demonstrated significantly higher intraoperative mean arterial pressure (92 ± 6 mmHg vs. 85 ± 8 mmHg, p = 0.02) and reduced incidence of tachycardia (15% vs. 35%, p = 0.04) and hypotension (10% vs. 30%, p = 0.04) compared to the midazolam group, reflecting improved hemodynamic stability. Conclusion: Nalbuphine offers superior perioperative hemodynamic stability compared to midazolam, suggesting its preferential use in orthopedic patients at risk for cardiovascular fluctuations and highlighting its value in optimizing surgical safety and recovery

Journal of Health Wellness and Community Research
University of Health and Allied Sciences (GH), Superior University (PK)
Openalex Percentile: Top 79%
Cardiac, Anesthesia and Surgical Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.